Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 7/20 | 0.39 |
| ▸ | CLCN2 | P51788 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAP2K1 | Q02750 | 2/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.33 |
| ▸ | SORT1 | Q99523 | 3/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14222462 | 0.89 | ALDH1A1 (0.36) | CLCN2NPC1ALDH1A1MAP2K1S1PR3 | |
| SCHEMBL14222530 | 0.88 | NPC1 (0.40) | DHODHNPC1ALDH1A1LMNAGAA | |
| SCHEMBL14219570 | 0.88 | DHODH (0.48) | DHODHCLCN2LMNAGAAMAP2K1 | |
| SCHEMBL14220139 | 0.88 | NPC1 (0.38) | DHODHCLCN2NPC1ALDH1A1LMNA | |
| SCHEMBL14219683 | 0.88 | LMNA (0.42) | DHODHCLCN2NPC1LMNAGAA | |
| SCHEMBL14219676 | 0.86 | MAP2K1 (0.40) | DHODHCLCN2LMNAGAAMAP2K1 | |
| SCHEMBL14222456 | 0.86 | DHODH (0.39) | DHODHCLCN2LMNAGAAMAP2K1 | |
| SCHEMBL14219655 | 0.85 | MAP2K1 (0.38) | NPC1ALDH1A1GAAMAP2K1S1PR3 | |
| SCHEMBL14219658 | 0.83 | MAP2K1 (0.39) | NPC1ALDH1A1MAP2K1EGFR | |
| SCHEMBL14222457 | 0.83 | DHODH (0.41) | DHODHCLCN2NPC1LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1908751-A1 | N-hydroxy benzamides with antitumour activity | EOS S.p.A. (IT) | 2008-04-09 | — | — | EP | disclosed |